37
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics

, , , , , , , , , , , , & show all
Pages 40-45 | Received 11 Mar 2009, Accepted 02 Sep 2009, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Hiroki Wakabayashi, Masahiro Hasegawa, Yosuke Nishioka, Akihiro Sudo & Kusuki Nishioka. (2012) Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study. Modern Rheumatology 22:1, pages 116-121.
Read now
Masahiko Mihara, Yoshiyuki Ohsugi & Tadamitsu Kishimoto. (2011) Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis. Open Access Rheumatology: Research and Reviews 3, pages 19-29.
Read now
Sally Hamour, Alan D Salama & Charles D Pusey. (2010) Management of ANCA-associated vasculitis: Current trends and future prospects. Therapeutics and Clinical Risk Management 6, pages 253-264.
Read now

Articles from other publishers (3)

Hema Chaplin, Lewis Carpenter, Anni Raz, Elena Nikiphorou, Heidi Lempp & Sam Norton. (2021) Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review. Rheumatology 60:8, pages 3540-3552.
Crossref
Jeroen DeGroot, Anne-Marie Zuurmond & Paul-Peter Tak. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 476 492.e6 .
Regina Rendas-Baum, Gene V Wallenstein, Tamas Koncz, Mark Kosinski, Min Yang, John Bradley & Samuel H Zwillich. (2011) Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors. Arthritis Research & Therapy 13:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.